Tumor Analysis
The addition of molecular technologies to standard pathological methods results in a better understanding of disease diagnosis. Molecular technologies are used to monitor infectious disease and cancer treatment, as well as determine disease severity by better characterizing pathogenicity.
Molecular technologies have further evolved and now play important roles in drug development and drug prescribing. Molecular technology is the key to the expanding role of healthcare screening and detection in preventing disease.
The molecular diagnostic facility is now expanding its testing capabilities. In addition to molecular diagnostic tests, faculty members perform research in the field of cancer biomarker studies. The molecular laboratory has been named a Roche Molecular Center of Excellence, the 25th center across the nation to become part of this prestigious network.
Laboratory Services
Immunohistochemistry
- Diagnostic testing for tumor classification
- Prognostic testing for HER2/neu oncogene
- DNA ploidy
- Ki67 (Mib-1)
- Estrogen and progesterone receptor
- Epidermal growth factor receptor (EGFR)
- p53
Molecular Diagnostics
- Fluorescence in situ hybridization (FISH)
- Detection of breast cancer Her2/Neu oncogene amplification
- Bladder cancer detection - UroVysion urinalysis
|
